| Phase 1/2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05118490 | Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To… | HIV Seropositivity | Active, Not Recruiting | 2025-12-12 |
| Phase 2/3 | ||||
| NCT05686356 | A Pan-TB Regimen Targeting Host and Microbe | Tuberculosis | Active, Not Recruiting | 2025-05-28 |
| Phase 1/2 | ||||
| NCT05122026 | Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and… | HIV Seropositivity | Active, Not Recruiting | 2025-12-12 |
| NCT05122767 | Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking… | Tuberculosis | Active, Not Recruiting | 2025-12-12 |
| Not applicable | ||||
| NCT06909799 | A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease | Tuberculosis (TB) | Recruiting | 2025-04-30 |